Subscribe to RSS
DOI: 10.1055/s-2006-950252
A Convenient One-Pot Synthesis of Spirocyclic Pyrido[1,2-a]indole Derivatives from 3-(2-Bromoethyl)indole
Publication History
Publication Date:
23 November 2006 (online)
Abstract
A convenient one-pot approach for the synthesis of spirocyclic pyrido[1,2-a]indole derivatives is described. The method involves treatment of 1,3-diketones and 1,3-ketoesters with base to generate dianions, which react with 3-(2-bromoethyl)indole to construct a spirocyclopropyl ring and an N-heterocyclic ring sequentially in moderate to very good yields.
Key words
spirocyclic pyrido[1,2-a]indole derivatives - tandem reactions - heterocycles.
-
1a
Joule JA. Science of Synthesis Vol. 10:Thomas EJ. Georg Thieme Verlag; Stuttgart: 2000. p.361-652 -
1b
Bosch J.Bonjoch J.Amat M. Alkaloids 1996, 48: 75 -
1c
Sundberg RJ. Indoles Academic Press; London: 1996. -
1d
Chadwick DJ.Jones RA.Sundberg RJ. Comprehensive Heterocyclic Chemistry Vol. 4: Pergamon; Oxford: 1984. p.155-376 -
2a
Saxton JE. The Chemistry of Heterocyclic Compounds Vol. 25, Part IV: Academic Press; New York: 1994. -
2b
Clark RD.Miller AB.Berger J.Repke DB.Weinhardt KK.Kowalczyk BA.Eglen RM.Bonhaus DW.Lee CH. J. Med. Chem. 1993, 36: 2645 -
3a
Gross S.Reissig H.-U. Org. Lett. 2003, 5: 4305 -
3b
Hiroi K.Hiratsuka Y.Watanabe K.Abe I.Kato F.Hiror M. Tetrahedron: Asymmetry 2002, 13: 1351 -
3c
Teuber HJ.Worbs E.Cornelius D. Arch. Pharm. 1982, 315: 388 -
3d
Ozaki S.Mitoh S.Ohmori H. Chem. Pharm. Bull. 1996, 44: 2020 - 4
Gribble GW. J. Chem. Soc., Perkin Trans. 1 2000, 1045 - 5
Bytschkov I.Siebeneicher H.Doye S. Eur. J. Org. Chem. 2003, 2888 - 6
Nicolaou KC.Roecker AJ.Hughes R.Summeren RV.Pfefferkorn JA.Winssinger N. Bioorg. Med. Chem. 2003, 11: 465 - 7
Closson WD.Roman SA.Kwiatkowski GT.Corwin DA. Tetrahedron Lett. 1966, 21: 2271 - 8
Johansen JE.Christie BD.Rapoport H. J. Org. Chem. 1981, 46: 4914 - 9
Amombo MO.Hausherr A.Reissig H.-U. Synlett 1999, 1871 -
10a
Clive DLJ.Wang J.Yu M. Tetrahedron Lett. 2005, 46: 2853 -
10b
Rubiralta M.Diez A.Vila C.Troin Y.Feliz M. J. Org. Chem. 1991, 56: 6292 - 11
Huckin SN.Weiler L. J. Am. Chem. Soc. 1974, 96: 1082 -
14a
Revuelta J.Cicchi S.Brandi A. J. Org. Chem. 2005, 70: 5636 -
14b
Cicchi S.Revuelta J.Zanobini A.Betti M.Brandi A. Synlett 2003, 2305
References and Notes
General Procedure for Reaction Protocol: NaH (12 mmol, 0.29 g) was weighed out with a flask in a dry box and then THF (40 mL) was added. The flask was placed in an ice bath. The mixture was stirred and 1,3-diketones or 1,3-ketoesters 4 (6 mmol) in THF (5 mL) was added dropwise into the flask. The mixture was further stirred for 10 min at 0 °C and then n-BuLi (12 mmol, 7.6 mL of 1.6 M n-BuLi solution in hexane) was added dropwise. After 20 min, 3-(2-bromo-ethyl) indole (5 mmol, 1.12 g) in THF (5 mL) was added dropwise with stirring. The reaction mixture was warmed to r.t. slowly and further stirred overnight. The reaction mixture was hydrolyzed with 1% HCl solution (30 mL) and extracted with Et2O. The combined organic extracts were washed with H2O and dried over MgSO4. After filtration, the crude product was concentrated and purified with column chromatography. The obtained pure products 5 were characterized with 500 MHz NMR, GC-MS, and HRMS.
13The NMR spectra were recorded with 500 MHz NMR spectrometer. GC-MS method: initial temperature: 50 °C (hold for 3 min), rate: 15 °C/min, final temperature: 280 °C (hold for 7 min). Compound 5a: The general procedure was followed with the use of substrate 4a (0.6 g) and product 5a (0.95g, 85%) was obtained as a brown solid after purification. 1H NMR (500 MHz, CDCl3): δ = 7.21 (d, J = 8.2 Hz, 1 H), 7.12 (t, J = 7.3 Hz, 1 H), 6.94 (t, J = 7.4 Hz, 1 H), 6.72 (d, J = 7.2 Hz, 1 H), 5.19 (s, 1 H), 4.41 (dd, J = 4.1, 16.5 Hz, 1 H), 2.47 (s, 3 H), 2.42 (t, J = 16.2 Hz, 1 H), 2.14 (dd, J = 4.0, 15.8 Hz, 1 H), 1.22-1.29 (m, 2 H), 0.90-0.95 (m, 1 H), 0.71-0.76 (m, 1 H). 13C NMR (125 MHz, CDCl3): δ = 191.5, 156.7, 143.1, 137.8, 127.2, 122.9, 119.5, 112.3, 104.4, 64.3, 38.4, 26.6, 22.5, 15.4, 12.1. GC-MS (t
R
= 19.96 min): m/z = 225 (56) [M+], 197 (100), 154 (48), 115 (13). HRMS (FAB): m/z [M + H+] calcd for C15H16ON: 226.1232; found: 226.1216.
5b: The general procedure was followed with the use of substrate 4b (0.68 g) and product 5b (0.97 g, 81%) was obtained as a orange-brown solid after purification. 1H NMR (500 MHz, CDCl3): δ = 7.18 (d, J = 8.2 Hz, 1 H), 7.10 (t, J = 7.5 Hz, 1 H), 6.88 (t, J = 7.4 Hz, 1 H), 6.69 (d, J = 7.4 Hz, 1 H), 4.30 (dd, J = 4.0, 16.4 Hz, 1 H), 2.50 (s, 3 H), 2.47 (t, J = 16.1 Hz, 1 H), 2.18 (dd, J = 3.9, 15.9 Hz, 1 H), 1.86 (s, 3 H), 1.21-1.27 (m, 2 H), 0.90-0.93 (m, 1 H), 0.73-0.76 (m, 1 H). 13C NMR (125 MHz, CDCl3): δ = 191.7, 153.8, 143.8, 137.8, 127.1, 121.8, 119.3, 111.9, 111.1, 64.0, 39.2, 29.9, 18.7, 14.9, 13.4, 10.6. GC-MS (t
R
= 20.02 min): m/z = 239 (100) [M+], 211 (90), 196 (20), 182 (35), 168 (88), 129 (18), 115 (29). HRMS (FAB): m/z [M + H+] calcd for C16H18ON: 240.1388; found: 240.1388.
5c: The general procedure was followed with the use of substrate 4c (0.97 g) and product 5c (1.09 g, 76%) was obtained as a brown-black solid after purification. 1H NMR (500 MHz, CDCl3): δ = 7.50-7.52 (m, 5 H), 6.79 (td, J = 1.0, 7.4 Hz, 1 H), 6.73 (td, J = 1.4, 7.5 Hz, 1 H), 6.65 (dd, J = 1.0, 7.3 Hz, 1 H), 5.71 (d, J = 8.2 Hz, 1 H), 5.38 (s, 1 H), 4.65 (dd, J = 4.0, 15.9 Hz, 1 H), 2.75 (t, J = 16.1 Hz, 1 H), 2.24 (dd, J = 4.0, 16.3 Hz, 1 H), 1.19-1.22 (m, 2 H), 1.08-1.12 (m, 1 H), 0.88-0.91 (m, 1 H). 13C NMR (125 MHz, CDCl3): δ = 192.4, 157.8, 145.1, 139.5, 135.7, 131.1, 128.0, 127.1, 122.6, 118.5, 116.2, 114.9, 108.8, 66.3, 39.9, 27.0, 16.0, 13.8. GC-MS (t
R
= 24.35 min): m/z = 287 (81) [M+], 258 (100), 230 (85), 154 (26), 129 (45). HRMS (FAB): m/z [M + H+] calcd for C20H18ON: 288.1388; found: 288.1390.
5d: The general procedure was followed with the use of substrate 4d (0.70 g) and product 5d (0.75 g, 66%) was obtained as a yellow solid after purification. 1H NMR (500 MHz, CDCl3; enol-keto mixture): δ = 8.15 (d, J = 8.0 Hz, 0.4 H), 7.20 (t, J = 7.5 Hz, 0.6 H), 7.06 (t, J = 7.4 Hz, 0.5 H), 6.97 (td, J = 1.0, 7.6 Hz, 0.9 H), 6.69 (d, J = 7.6 Hz, 0.6 H), 6.65 (t, J = 7.3 Hz, 0.8 H), 6.56 (t, J = 7.0 Hz, 1.6 H), 5.28 (s, 0.1 H), 4.67 (m, 0.5 H), 4.11 (m, 1 H), 3.73 (s, 3.5 H), 2.73 (m, 1 H), 2.51-2.59 (m, 2 H), 1.22-1.39 (m, 3 H), 0.79-1.03 (m, 6.5 H). 13C NMR (125 MHz, CDCl3): δ = 202.5, 167.3, 150.0, 133.3, 127.5, 127.0, 125.0, 118.8, 118.5, 116.0, 108.9, 59.8, 58.8, 52.5, 49.9, 49.5, 46.7, 42.3, 30.2, 28.0, 15.9, 15.5, 14.6, 12.2. GC-MS (t
R
= 19.26 min): m/z = 227 (35) [M+], 199 (82), 130 (100), 115 (48). HRMS (FAB):
m/z [M + H+] calcd for C14H14O2N: 228.1025; found: 228.1013.